Despite the efficacy of anti-4-1BB in expanding innate immune cells, as well as host T cells, we found that 4-1BB on the transferred T cells or on the host αβ T cells is necessary and sufficient for the effects of anti-4-1BB on adoptive tumor therapy against the E.G7 thymoma. The gene discussed is TNFRSF9; the disease is neoplasm.